Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

OSUR

OraSure Technologies (OSUR)

OraSure Technologies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:OSUR
일자시간출처헤드라인심볼기업
2022/05/1905:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1905:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1905:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1905:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1905:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1720:05GlobeNewswire Inc.InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 SubvariantsNASDAQ:OSUROraSure Technologies Inc
2022/05/1305:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/05/1221:15TipRanksAnalysts Conflicted on These Healthcare Names: Amicus (FOLD), Orasure Technologies (OSUR) and NanoString Tech (NSTG)NASDAQ:OSUROraSure Technologies Inc
2022/05/1106:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSUROraSure Technologies Inc
2022/05/1105:05GlobeNewswire Inc.OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID RevenueNASDAQ:OSUROraSure Technologies Inc
2022/05/0405:05GlobeNewswire Inc.OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ETNASDAQ:OSUROraSure Technologies Inc
2022/04/0905:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/04/0805:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSUROraSure Technologies Inc
2022/04/0805:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSUROraSure Technologies Inc
2022/04/0720:05GlobeNewswire Inc.OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome SamplesNASDAQ:OSUROraSure Technologies Inc
2022/04/0605:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/03/3120:05GlobeNewswire Inc.OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome SamplesNASDAQ:OSUROraSure Technologies Inc
2022/03/2905:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/03/2305:05GlobeNewswire Inc.OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to RoleNASDAQ:OSUROraSure Technologies Inc
2022/03/0518:09TipRanksOrasure Technologies (OSUR) Receives a Hold from J.P. MorganNASDAQ:OSUROraSure Technologies Inc
2022/02/2406:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSUROraSure Technologies Inc
2022/02/2406:05GlobeNewswire Inc.OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales UpNASDAQ:OSUROraSure Technologies Inc
2022/02/1706:05GlobeNewswire Inc.OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ETNASDAQ:OSUROraSure Technologies Inc
2022/02/1106:50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSUROraSure Technologies Inc
2022/02/1023:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSUROraSure Technologies Inc
2022/02/0406:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/02/0406:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/02/0406:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSUROraSure Technologies Inc
2022/01/3121:53Dow Jones NewsOraSure Gets Approval for Covid-19 Tests on Children 2 to 14 Years OldNASDAQ:OSUROraSure Technologies Inc
2022/01/3121:05GlobeNewswire Inc.InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting AppNASDAQ:OSUROraSure Technologies Inc
 검색 관련기사 보기:NASDAQ:OSUR